Equity Offerings (Details) - USD ($) |
3 Months Ended | ||
---|---|---|---|
Dec. 06, 2021 |
Mar. 31, 2022 |
Mar. 31, 2021 |
|
Net proceeds from the sale of common shares | $ 15,547,815 | $ 1,542,465 | |
Common stock issued under prospectus supplement dated April 9, 2021 | |||
Number of shares issued during the period | 2,730,725 | ||
Common stock issued under prospectus supplement dated December 6, 2021 | |||
Net proceeds from the sale of common shares | $ 15,547,815 | ||
Common stock shares available for sale | 22,118,520 | ||
ATM | |||
Number of shares issued during the period | 303,407 | ||
Net proceeds from the sale of common shares | $ 1,542,465 | ||
ATM | Common stock issued under prospectus supplement dated December 6, 2021 | |||
Authorized amount to be issued | $ 44,925,000 |
X | ||||||||||
- Definition Represents the authorized amount to be issued. No definition available.
|
X | ||||||||||
- Definition The number of common stock shares available for sale. No definition available.
|
X | ||||||||||
- Definition The cash inflow from the additional capital contribution to the entity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of new stock issued during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|